Climate adaptation investment surges sixty-four percent to five-point-five billion in 2025 — Trellis
Climate adaptation technologies grew 64 percent to $5.5 billion in 2025, spanning climate risk intelligence, flood forecasting, water management, and resilience tools for communities and businesses.
Positive-sum angle: Adaptation tech creates compounding value by making existing infrastructure and agriculture more resilient rather than replacing it. Every dollar spent on early-warning systems or water conservation multiplies across downstream industries—insurance, agriculture, real estate, logistics.
What's the impact: ASEAN sits at the climate-risk frontier: typhoons, flooding, rising seas. SEA founders should build adaptation layers for agriculture and supply-chain logistics before the insurance industry mandates them. The arbitrage is selling resilience as a product, not a compliance cost.
Cell and gene therapy investment hits fifteen-point-two billion as biotech turns infrastructure — Mean CEO
Industry reporting highlights rising investment in personalized medicine and cell and gene therapies, with $15.2 billion deployed in 2025 as biotech transitions from niche science to business infrastructure.
Positive-sum angle: Biotech becoming infrastructure means it now powers manufacturing, agriculture, and environmental sectors beyond pharma. Enzymes, biomaterials, and fermentation processes reduce carbon intensity across supply chains, turning every factory into a potential biotech customer.
What's the impact: Singapore and Thailand have clinical and manufacturing depth. SEA operators should map which biotech platforms unlock cost or carbon savings in palm oil, textiles, or food production, then partner before the tech locks into exclusive deals with multinationals.